Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). (Q44308339)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). |
scientific article |
Statements
Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL) (English)
Josette Briere
Christian Gisselbrecht
Jean-Francois Emile
Pierre Lederlin
Catherine Sebban
Francoise Berger
Andre Bosly
Pierre Morel
Herve Tilly
Reda Bouabdallah
Felix Reyes
Philippe Gaulard
Bertrand Coiffier
6 February 2003